Correlation Between Novo Nordisk and ChitogenX
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and ChitogenX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and ChitogenX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and ChitogenX, you can compare the effects of market volatilities on Novo Nordisk and ChitogenX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of ChitogenX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and ChitogenX.
Diversification Opportunities for Novo Nordisk and ChitogenX
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Novo and ChitogenX is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and ChitogenX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChitogenX and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with ChitogenX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChitogenX has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and ChitogenX go up and down completely randomly.
Pair Corralation between Novo Nordisk and ChitogenX
Considering the 90-day investment horizon Novo Nordisk AS is expected to generate 0.23 times more return on investment than ChitogenX. However, Novo Nordisk AS is 4.38 times less risky than ChitogenX. It trades about -0.16 of its potential returns per unit of risk. ChitogenX is currently generating about -0.23 per unit of risk. If you would invest 11,236 in Novo Nordisk AS on August 28, 2024 and sell it today you would lose (780.00) from holding Novo Nordisk AS or give up 6.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 95.45% |
| Values | Daily Returns |
Novo Nordisk AS vs. ChitogenX
Performance |
| Timeline |
| Novo Nordisk AS |
| ChitogenX |
Novo Nordisk and ChitogenX Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and ChitogenX
The main advantage of trading using opposite Novo Nordisk and ChitogenX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, ChitogenX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChitogenX will offset losses from the drop in ChitogenX's long position.| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |